MRM Health

Ghent, Belgium · Founded 2020 · Privately Held (backing)

Developer of a clinical-stage biopharmaceutical platform designed to create microbiome-based live biotherapeutic products to address chronic inflammatory diseases. MRM Health is based in Ghent, Belgium and was founded in 2020. Its last reported valuation was $67.1 million in Sep 2025. It has raised $88.7 million.

Last reported valuation
$67.1M
Oct 2026
Priced at
—
Total raised
$88.7M
Last round
—

MRM Health key facts

as of Oct 2026
  • Developer of a clinical-stage biopharmaceutical platform designed to create microbiome-based live biotherapeutic products to address chronic inflammatory diseases.
  • MRM Health is valued at approximately $67.1M as of Oct 2026 (last reported valuation).
  • It has raised $88.7M; the latest was Later Stage VC ($64.2M) in Sep 2025.
  • Notable investors include Korys Investments, Société Fédérale de Participations et d'Investissement, VIB, BNP Paribas Fortis Private Equity, Ackermans & van Haaren — 15 tracked in total.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$67.1M

MRM Health's last reported valuation, Sep 2025. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of MRM Health with a free account
  • ·The complete investor list: 15 names
  • ·Watch MRM Health: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

MRM Health funding rounds

No rounds on record

No funding rounds for MRM Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

MRM Health valuation

MRM Health's last reported valuation was $67.1 million in Sep 2025. No priced round, secondary trade or fund mark has surfaced since.

MRM Health investors

About MRM Health

Developer of a clinical-stage biopharmaceutical platform designed to create microbiome-based live biotherapeutic products to address chronic inflammatory diseases. The company offers a proprietary platform with advanced bioinformatics-guided strain design, optimized microbial consortia development and standardized manufacturing, enabling healthcare researchers and clinicians to explore new therapeutic approaches for patients with inflammatory bowel conditions and complex health challenges.

Sector
Healthcare
HQ
Ghent, Belgium
Founded
2020
Employees
41
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.